|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02552 HUA MEDICINE-B
Nominal 
1.740 -0.020 (-1.136%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -14.840% | -20.099% | -30.992% | -32.052% | -30.987% |
| ROAE (%) | -110.962% | -55.762% | -55.077% | -43.849% | -34.517% |
| Return on Capital Employed (%) | -14.337% | -21.810% | -40.887% | -36.002% | -37.115% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 48.785% | 43.690% | N/A | N/A | N/A |
| EBITDA Margin (%) | -239.657% | -979.050% | N/A | N/A | N/A |
| Pre-tax Profit Margin (%) | -275.726% | -1156.355% | N/A | N/A | N/A |
| Net Profit Margin (%) | -275.726% | -1156.355% | N/A | N/A | N/A |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 6.239 X | 4.991 X | 6.592 X | 9.810 X | 10.300 X |
| Quick Ratio (X) | 6.062 X | 4.981 X | 6.592 X | 9.810 X | 10.300 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 94.137% | 75.071% | 50.160% | 38.883% | 15.462% |
| Total Debt / Total Assets (%) | 9.723% | 8.701% | 7.916% | 6.735% | 7.172% |
| Net Debt / Total Assets (%) | -74.944% | -35.047% | -66.815% | -79.379% | -80.951% |
| Total Debt / Shareholders' Funds (%) | 165.845% | 34.903% | 15.883% | 11.019% | 8.484% |
| Long Term Debt / Shareholders' Funds (%) | 124.846% | 15.083% | 12.931% | 9.449% | 7.350% |
| Net Debt / Shareholders' Funds (%) | -1278.356% | -140.586% | -134.059% | -129.881% | -95.757% |
| Net Cash / (Debt) ($) | 1.293B | 393.050M | 603.710M | 951.375M | 1.016B |
| Net Cash / (Debt) per share ($) | 1.225 | 0.372 | 0.572 | 0.902 | 0.963 |
| Total Debt / Capital Employed (%) | 11.386% | 10.458% | 8.978% | 7.392% | 7.853% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 216.520 Day | 70.532 Day | N/A | N/A | -- |
| Receivables Turnover (Day) | 28.010 Day | 230.647 Day | N/A | N/A | N/A |
| Payables Turnover (Day) | 172.983 Day | 464.230 Day | N/A | N/A | N/A |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -142,241,000 |
| %Change | 57.877% |
| EPS / (LPS) | RMB -0.150 |
| NBV Per Share (¥) | RMB -0.031 |